Rita J Desai
Examiner (ID: 14900, Phone: (571)272-0684 , Office: P/1625 )
Most Active Art Unit | 1625 |
Art Unit(s) | 1612, 1625 |
Total Applications | 2152 |
Issued Applications | 1290 |
Pending Applications | 146 |
Abandoned Applications | 716 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 15054791
[patent_doc_number] => 10457684
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-29
[patent_title] => [1,2,3]triazolo[4,5-d]pyrimidine derivatives
[patent_app_type] => utility
[patent_app_number] => 16/228535
[patent_app_country] => US
[patent_app_date] => 2018-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11479
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16228535
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/228535 | [1,2,3]triazolo[4,5-d]pyrimidine derivatives | Dec 19, 2018 | Issued |
Array
(
[id] => 14230425
[patent_doc_number] => 20190127385
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => NOVEL [1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 16/228543
[patent_app_country] => US
[patent_app_date] => 2018-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7659
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16228543
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/228543 | [1,2,3]triazolo[4,5-D]pyrimidine derivatives | Dec 19, 2018 | Issued |
Array
(
[id] => 16991723
[patent_doc_number] => 20210230143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => CYCLOHEXYL ACID TRIAZOLE AZINES AS LPA ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 16/772825
[patent_app_country] => US
[patent_app_date] => 2018-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 72379
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16772825
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/772825 | Cyclohexyl acid triazole azines as LPA antagonists | Dec 17, 2018 | Issued |
Array
(
[id] => 18012099
[patent_doc_number] => 11504373
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-22
[patent_title] => Compounds and compositions for treating fibrosis
[patent_app_type] => utility
[patent_app_number] => 16/954514
[patent_app_country] => US
[patent_app_date] => 2018-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 12
[patent_no_of_words] => 11252
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16954514
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/954514 | Compounds and compositions for treating fibrosis | Dec 17, 2018 | Issued |
Array
(
[id] => 14185221
[patent_doc_number] => 20190112315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUGS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/221733
[patent_app_country] => US
[patent_app_date] => 2018-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27673
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16221733
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/221733 | Substituted polycyclic pyridone derivatives and prodrugs thereof | Dec 16, 2018 | Issued |
Array
(
[id] => 17578811
[patent_doc_number] => 20220135666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH A S1P MODULATOR
[patent_app_type] => utility
[patent_app_number] => 16/769983
[patent_app_country] => US
[patent_app_date] => 2018-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 294185
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16769983
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/769983 | TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH A S1P MODULATOR | Dec 12, 2018 | Pending |
Array
(
[id] => 14467693
[patent_doc_number] => 20190185489
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => MACROCYCLES AS PDE1 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/217754
[patent_app_country] => US
[patent_app_date] => 2018-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20632
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16217754
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/217754 | Macrocycles as PDE1 inhibitors | Dec 11, 2018 | Issued |
Array
(
[id] => 14158619
[patent_doc_number] => 20190106412
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-11
[patent_title] => SUBSTITUTED 3-AZABICYCLO[3.1.0]HEXANES AS KETOHEXOKINASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/211283
[patent_app_country] => US
[patent_app_date] => 2018-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28855
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16211283
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/211283 | SUBSTITUTED 3-AZABICYCLO[3.1.0]HEXANES AS KETOHEXOKINASE INHIBITORS | Dec 5, 2018 | Abandoned |
Array
(
[id] => 14500987
[patent_doc_number] => 20190194148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => TETRAZOLE-CONTAINING 1,2-CYCLOPROPANE-CARBOXAMIDES
[patent_app_type] => utility
[patent_app_number] => 16/211456
[patent_app_country] => US
[patent_app_date] => 2018-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48875
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16211456
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/211456 | TETRAZOLE-CONTAINING 1,2-CYCLOPROPANE-CARBOXAMIDES | Dec 5, 2018 | Abandoned |
Array
(
[id] => 14132303
[patent_doc_number] => 20190100541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-04
[patent_title] => DIOXOLANE ANALOGUES OF URIDINE FOR THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 16/208083
[patent_app_country] => US
[patent_app_date] => 2018-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19082
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16208083
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/208083 | Dioxolane analogues of uridine for the treatment of cancer | Dec 2, 2018 | Issued |
Array
(
[id] => 14132241
[patent_doc_number] => 20190100510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-04
[patent_title] => BROMOTRIAZOLE INTERMEDIATES
[patent_app_type] => utility
[patent_app_number] => 16/207360
[patent_app_country] => US
[patent_app_date] => 2018-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 183411
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16207360
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/207360 | Bromotriazole intermediates | Dec 2, 2018 | Issued |
Array
(
[id] => 17844895
[patent_doc_number] => 11434247
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-09-06
[patent_title] => Substituted furanopyrimidine compounds as PDE1 inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/766258
[patent_app_country] => US
[patent_app_date] => 2018-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 68036
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 450
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16766258
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/766258 | Substituted furanopyrimidine compounds as PDE1 inhibitors | Nov 25, 2018 | Issued |
Array
(
[id] => 14467603
[patent_doc_number] => 20190185444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => XANTHONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/199534
[patent_app_country] => US
[patent_app_date] => 2018-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20804
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16199534
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/199534 | Xanthone derivatives for the treatment of hepatitis B virus disease | Nov 25, 2018 | Issued |
Array
(
[id] => 16197378
[patent_doc_number] => 10722514
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-28
[patent_title] => Ubiquitin-specific-processing protease 7 (USP7) modulators and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/190123
[patent_app_country] => US
[patent_app_date] => 2018-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 88144
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 594
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16190123
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/190123 | Ubiquitin-specific-processing protease 7 (USP7) modulators and uses thereof | Nov 12, 2018 | Issued |
Array
(
[id] => 14342009
[patent_doc_number] => 20190152977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => SUBSTITUTED HETEROARYL COMPOUNDS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/186490
[patent_app_country] => US
[patent_app_date] => 2018-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86015
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 893
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16186490
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/186490 | Substituted heteroaryl compounds and methods of use | Nov 9, 2018 | Issued |
Array
(
[id] => 17697075
[patent_doc_number] => 11370785
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-28
[patent_title] => Multicyclic compounds as farnesoid X receptor modulators
[patent_app_type] => utility
[patent_app_number] => 16/759782
[patent_app_country] => US
[patent_app_date] => 2018-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48166
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 847
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16759782
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/759782 | Multicyclic compounds as farnesoid X receptor modulators | Oct 30, 2018 | Issued |
Array
(
[id] => 14422483
[patent_doc_number] => 10316031
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-11
[patent_title] => Compositions and methods for inhibiting kinases
[patent_app_type] => utility
[patent_app_number] => 16/169677
[patent_app_country] => US
[patent_app_date] => 2018-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12629
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16169677
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/169677 | Compositions and methods for inhibiting kinases | Oct 23, 2018 | Issued |
Array
(
[id] => 14213763
[patent_doc_number] => 20190119266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => COMPOSITIONS AND METHODS FOR INHIBITING KINASES
[patent_app_type] => utility
[patent_app_number] => 16/169683
[patent_app_country] => US
[patent_app_date] => 2018-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12613
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16169683
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/169683 | Compositions and methods for inhibiting kinases | Oct 23, 2018 | Issued |
Array
(
[id] => 13957797
[patent_doc_number] => 20190055242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-21
[patent_title] => INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1
[patent_app_type] => utility
[patent_app_number] => 16/166832
[patent_app_country] => US
[patent_app_date] => 2018-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41920
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16166832
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/166832 | Inhibitors of lysine specific demethylase-1 | Oct 21, 2018 | Issued |
Array
(
[id] => 15355383
[patent_doc_number] => 10526291
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-07
[patent_title] => Potent dual BRD4-kinase inhibitors as cancer therapeutics
[patent_app_type] => utility
[patent_app_number] => 16/166611
[patent_app_country] => US
[patent_app_date] => 2018-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 2
[patent_no_of_words] => 62740
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 209
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16166611
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/166611 | Potent dual BRD4-kinase inhibitors as cancer therapeutics | Oct 21, 2018 | Issued |